[ad_1]
Health
Teva Pharmaceutical Industries Ltd is recalling certain combinations of valsartan, a medicine for high blood pressure, as a result of the discovery of an impurity that can cause cancer, the latest worldwide recall of the drug.
PHOTO: A building of Teva Pharmaceutical Industries is seen in Jerusalem, Israel on December 14, 2017. REUTERS / Ammar Awad / File Photo
REUTERS: Teva Pharmaceutical Industries Ltd. is recalling certain associations of valsartan (antihypertensive) in the United States following the discovery of an impurity causing cancer, the latest worldwide recall of the drug.
The Israeli drug manufacturer will remember all lots of combined tablets of amlodipine-valsartan and amlodipine-valsartan-hydrochlorothiazide because of an impurity in an ingredient manufactured by a Mylan unit based in India, said Tuesday the FDA (Food and Drug Administration). (Http://bit.ly/2DOBSfu)
The European Union has actually banned last week https://www.reuters.com/article/us-mylan-valsartan-united-states/mylan-recalls-batches-of-blood-pressure-medicine-in- us-idUSKCN1NP2I3 sales of Valsartan manufactured by the Mylan India unit after the discovery of certain batches contained the same impurity, N-nitrosodiethylamine.
Teva has not received any reports of adverse events signaling a potential link or exposure to valsartan, said the health regulator.
Patients are advised to continue taking their medications as the risk of harm may be higher if treatment is discontinued immediately without comparable treatment, the FDA said.
(Report by Ankit Ajmera in Bengaluru, edited by Sriraj Kalluvila)
Source link
